N-Myc amplification in neuroblastoma is a poor prognostic factor [19] and in a recent study it could be demonstrated that only N-Myc amplified cell lines showed sensitivity to ABT-199, compared with N-Myc wildtype cell lines [13]. This evidence concerns the gene MYCN and neuroblastoma.